Nucleic Acid Loading into Extracellular Vesicles via PEI Transfection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for loading nucleic acids into extracellular vesicles, particularly those larger than 1000 base pairs, face challenges such as inefficiency, vesicle aggregation, and degradation, limiting their therapeutic and research applications.
Innovation Solution
A method for loading nucleic acid cargo, including DNA of varying lengths, into extracellular vesicles like red blood cell-derived vesicles using chemical transfection with Linear Polyethylenimine Hydrochloride, allowing for lumenal loading and repeated incubation cycles to enhance cargo uptake.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If exogenous loading methods like electroporation are used to load nucleic acids into extracellular vesicles, then loading can be achieved, but loading efficiency decreases significantly for nucleic acids larger than 1000 base pairs
Solution Approach 1:
The patent uses a cationic lipid-nucleic acid complex as an intermediary to facilitate loading. The cationic lipids form complexes with nucleic acids through electrostatic interactions, creating a bridging structure that enables efficient loading into extracellular vesicles without direct electroporation of large DNA molecules, thereby resolving the size limitation
Solution Approach 2:
The patent changes the physical-chemical parameters of the loading process by using chemical means (lipid-nucleic acid complex formation) instead of physical means (electroporation). This parameter change allows efficient loading of large DNA molecules (>1000 bp) that cannot be loaded effectively through traditional electroporation methods
2Quantity of substance
If large nucleic acids are loaded into extracellular vesicles using current methods, then cargo capacity increases, but vesicle aggregation and loss of yield occur
Solution Approach 1:
The cationic lipid acts as a protective intermediary between the nucleic acid cargo and the extracellular vesicle membrane. The lipid-nucleic acid complex forms a stable structure that prevents direct interactions causing aggregation, maintaining vesicle stability while enabling large cargo loading
Solution Approach 2:
The cationic lipid layer forms a flexible protective shell around the nucleic acid cargo. This lipid film stabilizes the vesicle structure and prevents aggregation, allowing large DNA molecules to be loaded without compromising vesicle integrity or causing yield loss
3Adaptability or versatility
If nucleic acids are loaded into extracellular vesicles, then therapeutic potential increases, but vulnerability to nucleases in systemic circulation persists
Solution Approach 1:
The cationic lipid layer forms a protective film around the nucleic acid cargo, creating a physical barrier that shields the vulnerable nucleic acids from nuclease degradation in systemic circulation. This protective shell maintains cargo integrity while enabling therapeutic applications
Solution Approach 2:
The patent creates a composite delivery system consisting of cationic lipids, nucleic acids, and extracellular vesicles. This composite structure combines the protective properties of lipids with the biological compatibility of EVs, providing dual protection against nuclease degradation while enhancing therapeutic potential
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the loading efficiency of nucleic acids into extracellular vesicles, enabling effective delivery of larger DNA molecules and improving their stability and therapeutic potential.
Implementation Method 1
chemical transfection with Linear Polyethylenimine Hydrochloride
Data Source
AI summary
An extracellular vesicle loaded with a nucleic acid cargo and method for preparing the loaded vesicle is disclosed.